- Home
- MNKD vs ROOT Comparison
MNKD vs ROOT Comparison
Compare MNKD & ROOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNKD | ROOT |
|---|---|---|
| Founded | 1991 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 943.7M |
| IPO Year | 2004 | 2020 |
Fundamental Metrics
Financial Performance| Metric | MNKD | ROOT |
|---|---|---|
| Price | $4.26 | $57.52 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 5 |
| Target Price | $8.69 | ★ $92.40 |
| AVG Volume (30 Days) | ★ 4.9M | 270.7K |
| Earning Date | 05-06-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 28.96 |
| EPS | N/A | ★ 3.58 |
| Revenue | $348,966,000.00 | ★ $1,517,100,000.00 |
| Revenue This Year | $35.81 | $11.73 |
| Revenue Next Year | $11.89 | $12.80 |
| P/E Ratio | ★ N/A | $15.77 |
| Revenue Growth | 22.23 | ★ 28.95 |
| 52 Week Low | $2.23 | $40.91 |
| 52 Week High | $6.51 | $104.47 |
Technical Indicators
Market Signals| Indicator | MNKD | ROOT |
|---|---|---|
| Relative Strength Index (RSI) | 57.43 | 53.99 |
| Support Level | $3.74 | $55.53 |
| Resistance Level | $4.55 | $60.52 |
| Average True Range (ATR) | 0.21 | 3.05 |
| MACD | 0.04 | 0.35 |
| Stochastic Oscillator | 83.12 | 75.75 |
Price Performance
Historical ComparisonAbout MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.
About ROOT Root Inc.
Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. It generates revenue from the sales of auto insurance policies within the United States.